Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

TCBP

TC BioPharm (TCBP)

TC BioPharm Holdings PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TCBP
日付受信時刻ニュースソース見出しコード企業名
2024/09/2105 : 00PR Newswire (US)/C O R R E C T I O N -- TC BioPharm/NASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/1221 : 30PR Newswire (US)TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical TrialNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0921 : 30PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0705 : 00PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0521 : 30PR Newswire (US)TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0321 : 30PR Newswire (US)TCBP Announces Dosing of 5 New Patients in ACHIEVENASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/3104 : 52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/3006 : 11Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2907 : 32Edgar (US Regulatory)Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2906 : 15PR Newswire (US)TC BioPharm Announces Closing of Upsized $6.0 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2902 : 50PR Newswire (US)TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral IndicationsNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2406 : 30Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/2405 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1705 : 20Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1602 : 00PR Newswire (US)TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1600 : 30PR Newswire (US)TC BioPharm Announces Closing of $2.0 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1523 : 47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1420 : 30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1405 : 30PR Newswire (US)TC BioPharm Announces Pricing of $2.0 Registered Direct OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/1313 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/0905 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/0705 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/07/3121 : 00PR Newswire (US)TCBP Announces Plan to Implement ADS Ratio ChangeNASDAQ:TCBPTC BioPharm Holdings PLC
2024/07/3005 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/07/2221 : 00PR Newswire (US)TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid LeukemiaNASDAQ:TCBPTC BioPharm Holdings PLC
2024/05/1521 : 30PR Newswire (US)TCBP Announces Launch of Compassionate Use Program for TCB008NASDAQ:TCBPTC BioPharm Holdings PLC
2024/05/0702 : 01PR Newswire (US)TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross ProceedsNASDAQ:TCBPTC BioPharm Holdings PLC
2024/05/0621 : 30PR Newswire (US)TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesNASDAQ:TCBPTC BioPharm Holdings PLC
2024/04/0421 : 32PR Newswire (US)TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesNASDAQ:TCBPTC BioPharm Holdings PLC
2024/04/0221 : 30PR Newswire (US)TCBP Increasing Treatment Capacity with Expanded Manufacturing ProcessNASDAQ:TCBPTC BioPharm Holdings PLC
 Showing the most relevant articles for your search:NASDAQ:TCBP

最近閲覧した銘柄

Delayed Upgrade Clock